Shiraz E-Medical Journal

Published by: Kowsar
Crossmark

Comparison of Serum Uric Acid Concentrations in Subjects With and Without Atrial Fibrillation

Mohammad Aghaali 1 , * , Seyed Fakhreddin Hejazi 2 , Leili Iranirad 2 and Akram Heidari 3
Authors Information
1 General Practitioner, Qom University of Medical Sciences, Qom, IR Iran
2 Department of Cardiology, Qom University of Medical Sciences, Qom, IR Iran
3 Department of Community Medicine, Qom University of Medical Sciences, Qom, IR Iran
Article information
  • Shiraz E-Medical Journal: February 01, 2016, 17 (2); e35007
  • Published Online: February 28, 2016
  • Article Type: Research Article
  • Received: December 11, 2015
  • Revised: January 15, 2016
  • Accepted: February 14, 2016
  • DOI: 10.17795/semj35007

To Cite: Aghaali M, Hejazi S F, Iranirad L, Heidari A. Comparison of Serum Uric Acid Concentrations in Subjects With and Without Atrial Fibrillation, Shiraz E-Med J. 2016 ; 17(2):e35007. doi: 10.17795/semj35007.

Abstract
Copyright © 2016, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
References
  • 1. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008; 359(17): 1811-21[DOI][PubMed]
  • 2. Watanabe E. Uric acid and atrial fibrillation - cause or other association? Circ J. 2012; 76(3): 584-5[PubMed]
  • 3. Wu XW, Muzny DM, Lee CC, Caskey CT. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol. 1992; 34(1): 78-84[PubMed]
  • 4. Hediger MA, Johnson RJ, Miyazaki H, Endou H. Molecular physiology of urate transport. Physiology (Bethesda). 2005; 20: 125-33[DOI][PubMed]
  • 5. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1981; 78(11): 6858-62[PubMed]
  • 6. Waring WS, Convery A, Mishra V, Shenkin A, Webb DJ, Maxwell SR. Uric acid reduces exercise-induced oxidative stress in healthy adults. Clin Sci (Lond). 2003; 105(4): 425-30[DOI][PubMed]
  • 7. Wyngaarden JB, Kelley WN. Gout and hyperuricemia. 1976;
  • 8. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999; 131(1): 7-13[PubMed]
  • 9. Hoieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U, et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int. 2004; 65(3): 1041-9[DOI][PubMed]
  • 10. Khoo CW, Krishnamoorthy S, Lim HS, Lip GY. Atrial fibrillation, arrhythmia burden and thrombogenesis. Int J Cardiol. 2012; 157(3): 318-23[DOI][PubMed]
  • 11. Yamashita T, Sekiguchi A, Iwasaki YK, Date T, Sagara K, Tanabe H, et al. Recruitment of immune cells across atrial endocardium in human atrial fibrillation. Circ J. 2010; 74(2): 262-70[PubMed]
  • 12. Watanabe E, Arakawa T, Uchiyama T, Kodama I, Hishida H. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol. 2006; 108(3): 346-53[DOI][PubMed]
  • 13. Liu T, Li L, Korantzopoulos P, Liu E, Li G. Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies. Int J Cardiol. 2008; 126(2): 160-70[DOI][PubMed]
  • 14. Letsas KP, Korantzopoulos P, Filippatos GS, Mihas CC, Markou V, Gavrielatos G, et al. Uric acid elevation in atrial fibrillation. Hellenic J Cardiol. 2010; 51(3): 209-13[PubMed]
  • 15. Celik M, Yalcinkaya E, Yuksel UC, Gokoglan Y, Bugan B, Kabul HK, et al. Increased serum uric acid levels are correlated with decreased left atrial appendage peak flow velocity in patients with atrial fibrillation. Med Princ Pract. 2015; 24(3): 263-8[DOI][PubMed]
  • 16. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005; 16(12): 3553-62[DOI][PubMed]
  • 17. Ruggiero C, Cherubini A, Miller E 3rd, Maggio M, Najjar SS, Lauretani F, et al. Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years. Am J Cardiol. 2007; 100(1): 115-21[DOI][PubMed]
  • 18. Tamariz L, Agarwal S, Soliman EZ, Chamberlain AM, Prineas R, Folsom AR, et al. Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol. 2011; 108(9): 1272-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments